Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances

Expectations High For Precision Medicine, Artificial Intelligence And RNA Technologies

The confluence of data science and molecular biology fuels expectations among biopharma industry leaders for another year of breakthrough innovation in human therapeutics. More than 70 executives and experts reveal what they are most excited about on the technology front.

Scrip Asks Part 5
• Source: Shutterstock

More from Scrip Asks

More from Scrip